Interfering Virus: A New Treatment Strategy For Flu
The UK's VirionHealth has taken £13m on board in a Series A to develop a novel approach to the treatment of influenza virus infections.
The UK's VirionHealth has taken £13m on board in a Series A to develop a novel approach to the treatment of influenza virus infections.